Pieris Pharmaceuticals Statistics

Total Valuation

PIRS has a market cap or net worth of $14.35 million. The enterprise value is -$12.02 million.

Market Cap	14.35M
Enterprise Value	-12.02M

Important Dates

The next estimated earnings date is Wednesday, May 8, 2024, before market open.

Earnings Date	May 8, 2024
Ex-Dividend Date	n/a

Share Statistics

PIRS has 1.24 million shares outstanding. The number of shares has increased by 21.43% in one year.

Shares Outstanding	1.24M
Shares Change (YoY)	+21.43%
Shares Change (QoQ)	+0.13%
Owned by Insiders (%)	7.44%
Owned by Institutions (%)	39.50%
Float	764,817

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.34
Forward PS	2.12
PB Ratio	0.54
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.24, with zero debt.

Current Ratio	3.24
Quick Ratio	2.45
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -86.70% and return on invested capital (ROIC) is -111.20%.

Return on Equity (ROE)	-86.70%
Return on Assets (ROA)	-36.70%
Return on Capital (ROIC)	-111.20%
Revenue Per Employee	$930,652
Profits Per Employee	-$533,543
Employee Count	46
Asset Turnover	0.64
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -81.89% in the last 52 weeks. The beta is 0.50, so PIRS's price volatility has been lower than the market average.

Beta (1Y)	0.50
52-Week Price Change	-81.89%
50-Day Moving Average	13.79
200-Day Moving Average	17.62
Relative Strength Index (RSI)	33.29
Average Volume (30 Days)	10,795

Short Selling Information

The latest short interest is 24,132, so 1.95% of the outstanding shares have been sold short.

Short Interest	24,132
Short Previous Month	134,126
Short % of Shares Out	1.95%
Short % of Float	3.16%
Short Ratio (days to cover)	0.02

Income Statement

In the last 12 months, PIRS had revenue of $42.81 million and -$24.54 million in losses. Loss per share was -$21.60.

Revenue	42.81M
Gross Profit	42.81M
Operating Income	-29.76M
Pretax Income	-24.54M
Net Income	-24.54M
EBITDA	-22.76M
EBIT	-24.54M
Loss Per Share	-$21.60

Full Income Statement

Balance Sheet

The company has $26.37 million in cash and no debt, giving a net cash position of $26.37 million or $21.32 per share.

Cash & Cash Equivalents	26.37M
Total Debt	n/a
Net Cash	26.37M
Net Cash Per Share	$21.32
Equity / Book Value	26.76M
Book Value Per Share	21.64
Working Capital	26.76M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$53.82 million and capital expenditures -$171,000, giving a free cash flow of -$53.99 million.

Operating Cash Flow	-53.82M
Capital Expenditures	-171,000
Free Cash Flow	-53.99M
FCF Per Share	-$47.96

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -69.51% and -57.33%.

Gross Margin	100.00%
Operating Margin	-69.51%
Pretax Margin	-57.33%
Profit Margin	-57.33%
EBITDA Margin	-53.17%
EBIT Margin	-57.33%
FCF Margin	-126.12%

Dividends & Yields

PIRS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-21.43%
Shareholder Yield	-21.43%
Earnings Yield	-171.08%
FCF Yield	-376.35%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on April 23, 2024. It was a reverse split with a ratio of 1:80.

Last Split Date	Apr 23, 2024
Split Type	Reverse
Split Ratio	1:80

Scores

PIRS has an Altman Z-Score of -10.83 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-10.83
Piotroski F-Score	2